December 24, 2005
Rost Sues Pfizer - Alleges Wrongful Dismissal

A few weeks ago in this blog, it was reported that Vice President of Marketing, Peter Rost was supposedly fired from Pfizer after he blew the whistle on Pharmacia which had supposedly sold human growth hormone for “non-permitted activities”.

At that time Rost had earlier launched a lawsuit against Pfizer on behalf of the government.

However, the story continues as Rost is now suing Pfizer for wrongful dismissal.

Based on the law in New Jersey, the Conscientious Employee Protection Act, it is “illegal to fire someone who complains of their employer’s illegal acts.” Pfizer released a statement that they feel that Rost has not basis for his allegations.



December 22, 2005
High School Athletes To Be Tested

An article written by staff writer Terrence Dopp on nj.com, stated that school officials in New Jersey will start testing school athletes for illegal use of human growth hormone and steroids.

The order was issued by acting Lt. Governor Richard Codey, after the results of a study conducted by a task force that Codey created.

The study showed that “3.4% of high school seniors nationwide, 2.4% of 10th graders, and 1.9% of eighth graders,” have used either human growth hormone or steroids.



December 21, 2005
Debating The Use Of Growth Hormone On Deficient Adults
An article on prnewswire.com stated that at the 13th Annual International Congress on Anti-aging Medicine, a lecture was presented on the legal issues surrounding using human growth hormone:

"The commentary suggests that the replacement of human growth hormone indeficient, aging adults is illegal because of a little-known federal law," said Mr. Collins, a legal authority on anabolic steroids and performance-enhancing hormones. "But the suggestion overlooks the historical context and intent of that law."

Mr. Collins went on to say that the use of steroids became a controlled substance in 1990 after a few athletes tested positive, however human growth hormone can be prescribed in medical situations.



December 20, 2005
Steroids and Human Growth Hormone Scandal

The West Palm Police Union has been rocked by a scandal involving thirteen officers who might have taken steroids and human growth hormone that was not prescribed.

This information was released after an investigation involving nine officers that tested positive for steroids after a drug test. The steroids and human growth hormone were supplied by PowerMedica.

The officers now face either suspension or termination, along with deputies in Broward County that were also supplied with steroids and human growth hormone.



December 17, 2005
HGH Increasing In Popularity

Based on an article appearing at Medindia.net, Human Growth Hormone has been increasing in popularity over its effects on age related illnesses other organs within the body.

The article went on to state, “Replacement therapy with Growth Hormone has shown a beneficial/normalizing effect on parameters such as cardiac and renal function, thyroid hormone, metabolism, bone metabolism, sweat secretion, total and regional fuel metabolism and psychological well being.”

The article then goes on to state that more people are interested in the research involving HGH, and conclusions cannot be drawn.



December 16, 2005
Sprinter At The Heart Of HGH Scandal Quits

Tim Montgomery called it quits today after he was involved in a scandal involving the use of human growth hormone.

Even though Montgomery states he is innocent, he feels that retiring instead of waiting out a two year ban will be much better. Montgomery stated, "That's the main concern because I don't know what to tell my kids," Montgomery said. "I don't know what to tell my mother and father, even though they say they love me and don't worry about it."

The ban came as a result of an investigation completed into the BALCO founder Victor Conte, who admitted to giving out steroids to a number of athletes.



December 16, 2005
Serono Laboratories Fined

According to information released today, Serono Laboratories will be forced to pay $704 million dollars stemming from kickbacks to doctors.

The details of the settlement reached were released after a US District judge handed down the sentence.

The settlement involves kickbacks that were given to doctors over the AIDS drug Serostim. Serostim is a protease inhibitor drug that contains the human growth hormone Somatotropin. Serono is said to conspired to increase the popularity of the drug using fraud by offering doctors money and free trips to hand out the drug.



December 15, 2005
Court Transcripts Released

Court transcripts were released yesterday detailing the conversations between Dr. James Shortt and former Carolina Panthers player Wesley Walls, as stated in an article appearing on mercurynews.com.

Dr. Shortt is on the hot seat for illegally distributing steroids. However, Walls only had this to say, “I went down there in February, whenever. It was for a consultation and I never went back."

>However, according to audiotapes and transcripts released, it might appear that Shortt advised Walls on steroid, DHEA, and HGH use,” Don't use a shot, because that's always got a carrier molecule in it," Shortt told Walls. The doctor advised Walls against an oral form of testosterone placed between the cheek and gum. The reason for that (is) it wouldn't take much of a stress for somebody to say, `Okay, spit in the cup,'" said Shortt. "And if you do, you'll come up sky high on it."



December 13, 2005
Iplex Approved By FDA

Insmed, Inc announced yesterday that the FDA had approved the use of the drug Iplex that it manufactures. Iplex is indicated for treating children with growth problems.

The drug will not be released until late 2006, but it will be used to treat children with a severe primary IGF-1 deficiency or deletion of the Growth Hormone gene.

The release of Insmed’s Iplex comes after Tecica Inc announced in late summer that the FDA had approved the use of its drug Increlex for treatment of IGF deficiency as well.



December 10, 2005
Tercica Announces Submission Of Marketing Application

Tercica announced submission of Marketing Application to the European Agency For Evaluation of Medicinal Products, for the right to sell Increlex in the European Union.

The FDA approved the use of Increlex ™ last August. It is primarily for use in people suffering from Primary Insulin Growth Factor Deficiency (IGFD) or Growth Hormone Gene Deletion.

Increlex ™ is the synthetic version of the hormone IGF, which is released in response to stimulation by Growth Hormone. By giving Increlex™ to children deficient in IGF, the, they should be able to increase in height.